Literature DB >> 18772025

Serotonin-dopamine interaction: an overview.

Ennio Esposito1, Vincenzo Di Matteo, Giuseppe Di Giovanni.   

Abstract

Central serotonergic and dopaminergic systems play a critical role in the regulation of normal and abnormal behaviours. Moreover, recent evidence suggests that the dysfunction of dopamine (DA) and serotonin (5-hydroxytriptamine, 5-HT) neurotransmission might underlie the pathophysiology of neuropsychiatric disorders, including depression, schizophrenia, attention deficit hyperactivity disorders, drug abuse, Gilles de la Tourette's syndrome and Parkinson's disease.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18772025     DOI： 10.1016/S0079-6123(08)00901-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


  28 in total

1.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

Authors:  Ramadhan Oruch; Anders Lund; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2010-01-27

Review 2.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

Review 3.  Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms.

Authors:  Allison G Harvey; Greg Murray; Rebecca A Chandler; Adriane Soehner
Journal:  Clin Psychol Rev       Date:  2010-04-24

4.  Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels.

Authors:  Philipp T Neukam; Nils B Kroemer; Yacila I Deza Araujo; Lydia Hellrung; Shakoor Pooseh; Marcella Rietschel; Stephanie H Witt; Uwe Schwarzenbolz; Thomas Henle; Michael N Smolka
Journal:  Psychopharmacology (Berl)       Date:  2018-05-05       Impact factor: 4.530

5.  An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.

Authors:  Meredith A Fox; Micaella G Panessiti; F Scott Hall; George R Uhl; Dennis L Murphy
Journal:  Psychopharmacology (Berl)       Date:  2013-02-17       Impact factor: 4.530

6.  Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA.

Authors:  M S Nandhu; Jes Paul; Korah P Kuruvila; Pretty M Abraham; Sherin Antony; C S Paulose
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

7.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

Review 8.  Does the difference between physically active and couch potato lie in the dopamine system?

Authors:  Amy M Knab; J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2010-03-09       Impact factor: 6.580

Review 9.  Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions.

Authors:  Cristiano Bombardi; Giuseppe Di Giovanni
Journal:  Exp Brain Res       Date:  2013-04-17       Impact factor: 1.972

10.  Serotonin syndrome following levodopa treatment in diffuse Lewy body disease.

Authors:  Suman Kushwaha; Akhila Kumar Panda; Hardeep Singh Malhotra; Manmeet Kaur
Journal:  BMJ Case Rep       Date:  2014-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.